TY  - GEN
AU  - Mingot-Castellano, Maria Eva
AU  - Bastida, Jose Maria
AU  - Caballero-Navarro, Gonzalo
AU  - Entrena Ureña, Laura
AU  - Gonzalez-Lopez, Tomas Jose
AU  - Gonzalez-Porras, Jose Ramon
AU  - Butta, Nora
AU  - Canaro, Mariana
AU  - Jimenez-Barcenas, Reyes
AU  - Gomez-Del-Castillo-Solano, Maria Del Carmen
AU  - Sanchez-Gonzalez, Blanca
AU  - Pascual-Izquierdo, Cristina
PY  - 2022
DO  - 10.3390/ph15070779
SN  - 1424-8247
UR  - http://hdl.handle.net/10668/21535
T2  - Pharmaceuticals (Basel, Switzerland)
AB  - Primary immune thrombocytopenia (ITP) is an autoimmune disorder that causes low platelet counts and subsequent bleeding risk. Although current corticosteroid-based ITP therapies are able to improve platelet counts, up to 70% of subjects with an ITP...
LA  - en
PB  - MDPI AG
KW  - autoantibodies
KW  - immune thrombocytopenia
KW  - platelets
KW  - targeted therapies
KW  - thrombopoietin
KW  - Adrenal Cortex Hormones
KW  - Splenectomy
KW  - Purpura, Thrombocytopenic, Idiopathic
KW  - Autoantibodies
KW  - Rituximab
KW  - Platelet Count
KW  - fostamatinib
TI  - Novel Therapies to Address Unmet Needs in ITP.
TY  - review
VL  - 15
ER  -